Two drug strategies boost myelin repair in MS models, cutting neuroinflammation

Multiple sclerosis (MS) is most prevalent in Northern Europe and Canada, and more common in the northernmost latitudes. In recent years, the number of cases has grown, particularly among women. The disease causes the patient's own immune system to attack a protective coating known as myelin that sur